Webinars

Upcoming Webinars

Past Webinars

Artificial Intelligence: Regulatory Affairs Evolution Utilizing AI
Wednesday, November 29, 2023
Presented by Meredith Brown-Tuttle, MWA Consultant
View the Webinar Recording 

In this presentation, we will explore the diverse toolkit now available to regulatory professionals in each discipline, encompassing both free and paid solutions. Drawing from firsthand experience, MWA Consultant Meredith Brown-Tuttle, will demonstrate how AI and other innovations have driven efficiency, time and money savings while maintaining quality.

Right Sizing Computer System Validation in Life Sciences 
Wednesday, September 20, 2023
Presented by Terri Mead, MWA Consultant
View the Webinar Recording 

Computer systems validation expert, Terri Hanson Mead, will provide a refresher on computer software assurance vs. computer system validation, the business case for validation, why validation is not just test execution nor can you solely rely on a vendor’s assertion that they provide a validated system, and some best practices for right sizing your validation approach.

Cell and Gene Therapy: Manufacturing and Development Challenges 
Wednesday, June 7, 2023
Presented by Matthew Kanter, MWA Associate
View the Webinar Recording

Learn more on the key regulations and guidance of Cell and Gene Therapy products, the specific challenges in manufacturing and development, and control and qualification strategies. 

Medical Devices-EU MDR Compliance
Thursday, March 30, 2023
Presented by Jason Jegge, MWA Associate
View the Webinar Recording

In this webinar, you will gain understanding of what the European (EU) Medical Device Regulation (MDR) is and why it came into effect. In addition, you will learn the current transition times, the changes from the MDD, and the EUDAMED reporting requirements.

The Essence of Good Laboratory Practices (GLP): What You Need to Know
Wednesday, August 11, 2021
Presented by Kim Frazier, MWA Associate
View the Webinar Recording

The drug development process is long and complex. In this webinar, you will gain understanding on where in the drug development timeline the GLPs apply. In addition, you will learn the basic elements of GLP, why early quality assurance practices matter, and how to avoid costly mistakes.

Inhalation Drug Development Process Overview
Wednesday, May 19, 2021
Presented by Aditya Das, Ph.D., MBA
Webinar recording available – email to request

Inhalation drugs offer a targeted approach in the fight against various respiratory diseases. Utilizing existing technologies with 505(b)(2) regulatory pathways, the industry is poised to move into a new phase of development. This webinar is meant to give an overview of the history of the inhalation drug market as well as to look at the potential for new growth and applications.

Remote Auditing: Best Practices and Practical Suggestions from MWA
Wednesday, April 21, 2021
View the Webinar Recording

Covid-19 taught us a few things about remote auditing. We’ll share how to address challenges as well as plan for best results. While the COVID-19 pandemic has disrupted our normal auditing processes due to the current on-site restrictions, our industry has (not surprisingly) adapted with new and improved ways of auditing to ensure we can continue to provide proper oversight of our contract services suppliers. MWA’s experienced auditors have shared their remote auditing experiences and best practices with us, which you will hear about during this webinar. One of our expert auditors will be available for questions at the end of the presentation. Training certificates will be available upon request for all verified attendees.

What to Expect in an FDA Inspection: CPGM-Updated PAI Guide
Wednesday, January 15, 2020
Download the presentation (PDF)

The FDA has published CPGMs (Compliance Program Guidance Manuals) for FDA Inspectors to follow when conducting inspections of Drug and Device establishments. In this webinar, MWA provides an overview of these manuals, where to find them and how to use them to prepare for FDA inspections of your facility or operations.

Keeping up with Regulations: Good Clinical Practice ICH E6(R2)
Wednesday, November 13, 2019
Download the presentation (PDF)

For over 20 years, the Good Clinical Practice Guidance document ICH E6 (R1) has been the guiding star for the conduct of clinical studies to ensure data integrity and patient safety. Since the ICH E6 (R1) was finalized in May 1996, the industry has changed from largely paper-based to electronic records, and clinical studies have become larger and more complex. With the shift to risk-based quality management, a need arose to modernize and update the GCP guidance. In this webinar, MWA provides an overview of the changes in the ICH E6(R2) integrated addendum, including the new additions to the glossary of terms defining a Certified Copy, Monitoring Plan and Validation of Computerized Systems.

Data Integrity: The Roadmap to Compliance
Wednesday, September 25, 2019
Download PDF of presentation (PDF)

Even with increased attention to Data Integrity, regulatory inspections continue to find many Data Integrity issues, such as failure to contemporaneously record information, failure to investigate failed test results, use of shared passwords, lack of audit trails, and failure to review electronic data. In this webinar, MWA will cover regulatory guidance, review FDA Warning Letters, and ALCOA+ and provide recommendations for meeting your compliance needs.

Implementing a Phase I Quality Management System (QMS)
Wednesday, July 17, 2019
Download Presentation (PDF)

If your company is involved in development or manufacturing for drugs, biologics, and/or medical devices, you must ensure compliance with regulatory requirements for managing quality. Implementation of a Quality Management System (QMS) must be appropriate for the phase of your product development. In this webinar, MWA will help you understand the important procedures you will need for a Phase I product, and provide recommendations for meeting your compliance needs.